Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1802]
News [2707]
Articles [198]
Editorials [1]
Conferences [135]
elearning [13]
Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in...
Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA
Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients ( Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA )
18 Feb 2023
Adjuvant nivolumab as standard of care for high-risk muscle-invasive urothelial...
Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA
Adjuvant nivolumab as standard of care for high-risk muscle-invasive urothelial carcinoma after radical resection ( Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA )
18 Feb 2023
JAVELIN Bladder 100: Avelumab maintenance indicated as a standard of care for...
Dr Srikala Sridhar - Princess Margaret Cancer Centre, Ontario, Canada
JAVELIN Bladder 100: Avelumab maintenance indicated as a standard of care for advanced urothelial carcinoma ( Dr Srikala Sridhar - Princess Margaret Cancer Centre, Ontario, Canada )
16 Feb 2023
HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer
Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain
HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer ( Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain )
7 Feb 2023
The role of lymph nodes in stage 3 lung cancer
Prof Walter Weder - Privatklinik Bethanien,Zürich, Switzerland
The role of lymph nodes in stage 3 lung cancer ( Prof Walter Weder - Privatklinik Bethanien,Zürich, Switzerland )
1 Feb 2023
The role of multidisciplinary tumour board in managing stage 3 lung cancer
Prof Walter Weder - Privatklinik Bethanien, Zürich, Switzerland
The role of multidisciplinary tumour board in managing stage 3 lung cancer ( Prof Walter Weder - Privatklinik Bethanien, Zürich, Switzerland )
1 Feb 2023
The advancements in radiotherapy for breast cancer patients
Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia
The advancements in radiotherapy for breast cancer patients ( Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia )
1 Feb 2023
Loco-regional management after neoadjuvant chemotherapy
Prof Terry Mamounas - Orlando Health Cancer Institute, Orlando, USA
Loco-regional management after neoadjuvant chemotherapy ( Prof Terry Mamounas - Orlando Health Cancer Institute, Orlando, USA )
1 Feb 2023
Management of HER2 positive metastatic breast cancer treatment algorithm
Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA
Management of HER2 positive metastatic breast cancer treatment algorithm ( Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA )
31 Jan 2023
Post neoadjuvant management in BRCA mutant breast cancer patients
Prof Banu Arun - MD Anderson Cancer Center, Houston, USA
Post neoadjuvant management in BRCA mutant breast cancer patients ( Prof Banu Arun - MD Anderson Cancer Center, Houston, USA )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 6: EONS Sessions
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 6: EONS Sessions ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 5: GI Oncology
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 5: GI Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation